Home > Cashflow Statement > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Cash Flow from Operating Activities

    Back to Cashflow Statement
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Cash Flow from Operating Activities ₹18 Cr₹75 Cr₹38 Cr₹17 Cr₹14 Cr

What is the latest Cash Flow from Operating Activities ratio of NATH BIOGENES (INDIA) ?

The latest Cash Flow from Operating Activities ratio of NATH BIOGENES (INDIA) is ₹18 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹18 Cr
Mar2024₹75 Cr
Mar2023₹38 Cr
Mar2022₹17 Cr
Mar2013₹14 Cr

How is Cash Flow from Operating Activities of NATH BIOGENES (INDIA) Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹18 Cr
-76.43
Mar2024 ₹75 Cr
94.42
Mar2023 ₹38 Cr
125.05
Mar2022 ₹17 Cr
19.96
Mar2013 ₹14 Cr -

Compare Cash Flow from Operating Activities of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹310.7 Cr -2.9% -3.7% -20.6% Stock Analytics
KAVERI SEED COMPANY ₹4,476.7 Cr -4.5% -0.5% -27.2% Stock Analytics
VENKYS (INDIA) ₹2,091.6 Cr 3.9% 7.6% -12.5% Stock Analytics
AVT NATURAL PRODUCTS ₹1,065.4 Cr -1.5% -0.3% 6.7% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹913.3 Cr -3.2% -10.5% NA Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹553.3 Cr -2.9% 0.8% 9.3% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-2.9%

-3.7%

-20.6%

SENSEX

-0.3%

4.9%

-7%


You may also like the below Video Courses